Skip to main content
. 2020 Jul 30;48(5):715–722. doi: 10.1007/s15010-020-01468-7

Table 2.

Analysis and comparison of various indicators of the study population on the first day of admission

Survival group (n = 53) Non-survival group (n = 36) z value P value
Leukocyte count (109/L) 4.59 (3.57, 5.935) 8.91 (5.627, 13.442) − 5.095 < 0.001
Neutrophil count (109/L) 2.58 (2.115, 4.035) 7.865 (4.365, 12.215) − 5.538 < 0.001
Lymphocyte count (109/L) 1.11 (0.865, 1.525) 0.71 (0.435, 1.087) − 3.553 < 0.001
Hemoglobin (g/L) 129 (116.5, 140) 121.50 (91.75, 134) − 2.425 0.015
Platelet count (109/L) 176 (132, 230) 185 (131.25, 264.25) − 0.435 0.664
CRP(mg/L) 24.0 (12.5, 49.6) 47.8 (13, 112.925) − 1.915 0.056
Serum amyloid A (mg/L) 200 (87.52, 200) 133.88 (63.635, 200) − 1.426 0.154
Procalcitonin (μg/L) 0.04 (0.04, 0.04) 0.194 (0.069, 2.111) − 6.419 < 0.001
ALT/AST 0.79 (0.595, 1.00) 0.755 (0.57, 0.895) − 0.928 0.353
Albumin (g/L) 38.9 (37.0, 41.8) 34.6 (30.4, 37.1) − 5.020 < 0.001
Lactate dehydrogenase (μ/L) 242 (175, 309) 417 (234, 511) − 3.849 < 0.001
Urea nitrogen (μmol/L) 4.02 (3.405, 5.08) 9.81 (5.47, 20.875) − 5.480 < 0.001
Creatinine (μmol/L) 58 (51, 72) 87 (57.75, 182.25) − 3.734 < 0.001
Blood glucose (mmol/L) 5.2 (4.81, 6.375) 6.285 (5.072, 8.655) − 2.934 0.003
GFR (mL/min) 103.55 (96.83, 113.35) 66.595 (27.977, 96.732) − 5.726 < 0.001
Prothrombin time (s) 11.8 (11.3, 12.25) 12.35 (11.525, 14.6) − 1.774 0.076
PT activity (%) 89.7 (81.5, 95) 78.15 (58.125, 92.995) − 2.512 0.012
INR 1.05 (1, 1.20) 1.09 (0.99, 1.27) − 0.280 0.779
APTT (s) 29.8 (26.8, 34.635) 30.15 (25.5, 34.15) − 0.581 0.561
Fibrinogen (g/L) 4.05 (3.29, 5.045) 4.16 (3.395, 5.76) − 0.614 0.539
d-dimer (mg/L) 0.66 (0.54, 0.915) 1.61 (0.677, 4.49) − 4.035 < 0.001
Antithrombin III activity (%) 87.8 (80.5, 90.615) 79.15 (72.025, 87.545) − 3.185 0.001

ALT alanine aminotransferase, AST aspartate aminotransferase, GFR glomerular filtration rate, INR PT international standardized ratio, APTT activated partial thrombin time, CRP C-reactive protein